<article>
<section>
<h1 id="header">Isolation, culture, and immunostaining of neonatal rat ventricular myocytes</h1>
<p><time datetime="2021-11-19">Published: November 19, 2021</time></p>
<p>Ana Helena Macedo Pereira,<sup><a href="#aff1">1</a>,<a href="#fn1">2</a></sup> Alisson Campos Cardoso,<sup><a href="#aff1">1</a>,<a href="#fn2">3</a>,<a href="#cor1">*</a></sup> and Kleber Gomes Franchini<sup><a href="#aff1">1</a>,<a href="#fn2">3</a>,<a href="#cor2">**</a></sup></p>
<p id="aff1"><sup>1</sup>Brazilian Biosciences National Laboratory, Brazilian Center for Research in Energy and Materials (CNPEM), Campinas, Sao Paulo, Brazil</p>
<p id="fn1"><sup>2</sup>Technical contact</p>
<p id="fn2"><sup>3</sup>Lead contact</p>
<p id="cor1"><sup>*</sup>Correspondence: <a href="mailto:alisson.cardoso@lnbio.cnpem.br">alisson.cardoso@lnbio.cnpem.br</a></p>
<p id="cor2"><sup>**</sup>Correspondence: <a href="mailto:kleber.franchini@lnbio.cnpem.br">kleber.franchini@lnbio.cnpem.br</a></p>
<p><span class="open-access">Open Access</span> • DOI: <a href="https://doi.org/10.1016/j.xpro.2021.100950">10.1016/j.xpro.2021.100950</a></p>
</section>
<section>
<h2 id="summary">Summary</h2>
<p>Isolation and culture of ventricular cardiomyocytes from neonatal rats (NRVMs) is a powerful model to study neonatal cardiac development, cell cycle regulation, and cardiac physiology and pathology <i>in vitro</i>. Here, we present our modified enzymatic digestion protocol followed by two-step discontinuous Percoll gradient centrifugation to isolate a high yield of viable ventricular cardiomyocytes from neonatal rats. Finally, here we describe an immunostaining protocol for cytosolic and nuclear staining of NRVMs.</p>
<p>For complete details on the use and execution of this protocol, please refer to <a class="external-link" href="http://refhub.elsevier.com/S2666-1667(21)00656-0/sref5">Pereira et al. (2020)</a>.</p>




<div class="highlights">
<h3>Highlights</h3>
<ul>
<li>Isolate a high yield of viable ventricular cardiomyocytes from neonatal rats (NRVMs)</li>
<li>NRVMs can be maintained in culture for several days</li>
<li>Enzymatic digestion of cardiac tissue and Percoll gradient separation</li>
<li>Detailed subsection of immunofluorescence for nuclear and cytosolic staining</li>
</ul>
</div>
<div class="graphical-abstract">
<h3>Graphical abstract</h3>
<figure><img src="https://prod-shared-star-protocols.s3.amazonaws.com/protocols/1171-GA.jpg" alt="GraphicalAbstract.jpg"></figure>
</div></section>
<section>
<h2 id="before-you-begin">Before you begin</h2>
<p>Prepare the solutions before you start the neonatal cardiomyocytes isolation. Refer to the <a href="#key-resources-table">key resources table</a> and <a href="#materials-and-equipment">materials and equipment</a> sections for a complete list of materials and equipment.</p>
<p>All solutions are sterile or sterile filtered, and tools are surface sterilization with 70% ethanol. All steps are performed in a sterile laminar flow cell culture hood. This protocol is intended to isolate neonatal rat hearts from two-three litters (approximately 30 pups). For work with neonatal rodents, please refer to your local institutional guidelines and rules set forth by the legislature and animal care programs, and adhere to your institutionally approved animal protocol. All methods described in this protocol have been approved by the CEUA CNPEM (protocol number 68).</p>
<h3 id="sec1.1">Prepare poly-D-lysine and laminin double-coated plates</h3>
<div class="timing">
<span class="timing-title">Timing:</span> 4 h</div>
<ol>
<li>Rinse the coverslips with distilled water.</li>
<li>Autoclave the coverslips in 100 mL glass bottle Schott containing 50 mL of distilled water.</li>
<li>Prepare a 100 μg/mL Poly-D-Lysine working solution in sterile, distilled water.</li>
<li>Using sterile forceps, transfer the coverslips to each well of a 6-well plate.</li>
<li>Add 1 mL of the 100 μg/mL Poly-D-Lysine working solution to each well of a 6-well plate.</li>
<li>Incubate the coated plates at room temperature for 1–2 h.</li>
<li>Remove the Poly-D-Lysine solution and rinse it three times with distilled water.</li>
<li>Prepare a 15 μg/mL working solution of laminin in sterile distilled water.</li>
<li>Add 1 mL of the 15 μg/mL laminin working solution to each well of a 6-well plate.</li>
<li>Incubate the coated plates at 37°C for 2 h or overnight at 4°C.</li>
<li>Before use, pre-warm the culture vessel to room temperature for at least 1 h before aspirating and discarding the laminin solution.</li>
</ol>
<div class="note">
<span class="note-title">Note:</span> You can use the coated culture plate immediately or store it at 4°C wrapped in laboratory film for up to 1 week.</div>
<div class="critical">
<span class="critical-title">Critical:</span> All steps should be performed in a sterile laminar flow cell culture hood. In addition, during the coating procedure, do not allow the plate to dry for extended periods at any point.</div>
</section>
<section>
<h2 id="key-resources-table">Key resources table</h2>
<table id="krt">
<thead>
<tr>
<th>REAGENT or RESOURCE</th>
<th>SOURCE</th>
<th>IDENTIFIER</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="3">Antibodies</td>
</tr>
<tr>
<td>Rhodamine Phalloidin</td>
<td>Invitrogen™</td>
<td>Cat# R415</td>
</tr>
<tr>
<td>α-Actinin antibody</td>
<td>Sigma-Aldrich</td>
<td>Cat#A7811</td>
</tr>
<tr>
<td>MEF2 antibody</td>
<td>Santa Cruz Biotechnology, Inc.</td>
<td>Cat#sc313</td>
</tr>
<tr>
<td>AlexaFluor-568-conjugated goat anti-mouse</td>
<td>Thermo Fisher Scientific</td>
<td>Cat# A-11004</td>
</tr>
<tr>
<td>AlexaFluor-488-conjugated goat anti-rabbit</td>
<td>Thermo Fisher Scientific</td>
<td>Cat# A-27034</td>
</tr>
<tr>
<td>AlexaFluor-488-Phalloidin</td>
<td>Thermo Fisher Scientific</td>
<td>Cat# A-12379</td>
</tr>
<tr>
<td colspan="3">Chemicals, peptides, and recombinant proteins</td>
</tr>
<tr>
<td>Collagenase, Type 2</td>
<td>Worthington Biochemical Corporation</td>
<td>Cat# LS004176</td>
</tr>
<tr>
<td>Percoll<sup>R</sup>
</td>
<td>Sigma-Aldrich</td>
<td>Cat# GE17-0891-01</td>
</tr>
<tr>
<td>Laminin Mouse Protein, Natural</td>
<td>Gibco™</td>
<td>Cat# 23017015</td>
</tr>
<tr>
<td>Poly-D-Lysine</td>
<td>Sigma-Aldrich</td>
<td>Cat# P7280</td>
</tr>
<tr>
<td>Horse Serum, New Zealand origin</td>
<td>Gibco™</td>
<td>Cat# 16-050-122</td>
</tr>
<tr>
<td>Fetal bovine serum</td>
<td>Vitrocell Embriolife</td>
<td>Cat# 50011</td>
</tr>
<tr>
<td>Penicillin-Streptomycin (10,000 U/mL)</td>
<td>Gibco™</td>
<td>Cat#15140122</td>
</tr>
<tr>
<td>Pancreatin from porcine pancreas</td>
<td>Sigma-Aldrich</td>
<td>Cat# P1750</td>
</tr>
<tr>
<td>Hepes sodium salt</td>
<td>Sigma-Aldrich</td>
<td>Cat# H7006-100G</td>
</tr>
<tr>
<td>NaCl</td>
<td>Merck</td>
<td>Cat# 1.06404-1000</td>
</tr>
<tr>
<td>NaH<sub>2</sub>PO<sub>4</sub>
</td>
<td>Merck</td>
<td>Cat# 1.06346.1000</td>
</tr>
<tr>
<td>D-glucose</td>
<td>Sigma-Aldrich</td>
<td>Cat# G5400</td>
</tr>
<tr>
<td>KCl</td>
<td>Sigma-Aldrich</td>
<td>Cat# P-9333</td>
</tr>
<tr>
<td>MgSO<sub>4</sub>.7H<sub>2</sub>O</td>
<td>Merck</td>
<td>Cat# 1.05886.1000</td>
</tr>
<tr>
<td>Sodium bicarbonate</td>
<td>Sigma-Aldrich</td>
<td>Cat# 55761</td>
</tr>
<tr>
<td>DMEM, powder, high glucose, pyruvate</td>
<td>Gibco™</td>
<td>Cat# 12800017</td>
</tr>
<tr>
<td>Phenol Red</td>
<td>Sigma-Aldrich</td>
<td>Cat# P3532-5g</td>
</tr>
<tr>
<td>DAPI</td>
<td>Sigma-Aldrich</td>
<td>Cat# D9542</td>
</tr>
<tr>
<td>Glycine</td>
<td>Sigma-Aldrich</td>
<td>Cat# G7126</td>
</tr>
<tr>
<td>Bovine Serum Albumin lyophilized powder (BSA)</td>
<td>Sigma-Aldrich</td>
<td>Cat# A3733</td>
</tr>
<tr>
<td>VECTASHIELD® Mounting Medium</td>
<td>Vector Laboratories</td>
<td>Cat# H-1000-100</td>
</tr>
<tr>
<td colspan="3">Experimental models: Organisms/strains</td>
</tr>
<tr>
<td>Neonatal Wistar HanUnib Rats (1–3 days old)</td>
<td>CEMIB/Unicamp, Campinas, SP</td>
<td>Protocol CEUA #68</td>
</tr>
<tr>
<td colspan="3">Other</td>
</tr>
<tr>
<td>50 mL/100 mL beakers</td>
<td>Pyrex®</td>
<td>CLS100050</td>
</tr>
<tr>
<td>Laboratory bottle (Schott) with cap</td>
<td>Boeco®</td>
<td>Z305200</td>
</tr>
<tr>
<td>0.22μm filter</td>
<td>Millex Millipore</td>
<td>SLGV033RB</td>
</tr>
<tr>
<td>15 mL and 50 mL Centrifuge tube</td>
<td>Falcon A Corning Brand</td>
<td>Ref 352070</td>
</tr>
<tr>
<td>20 mL Syringe</td>
<td>BD Plastipak</td>
<td>Ref 990173</td>
</tr>
<tr>
<td>6-wells cell culture plate standard</td>
<td>SARSTEDT</td>
<td>Ref 833920</td>
</tr>
<tr>
<td>5, 10mL Serological pipette</td>
<td>SARSTEDT</td>
<td>Ref 861253001</td>
</tr>
<tr>
<td>Refrigerated centrifuge</td>
<td>Eppendorf</td>
<td>5810R</td>
</tr>
<tr>
<td>Inverted microscope</td>
<td>Nikon</td>
<td>TMS-F</td>
</tr>
<tr>
<td>Confocal microscope</td>
<td>Leica Microsystems</td>
<td>TCS SP8</td>
</tr>
<tr>
<td>Large Incubated and Refrigerated Benchtop Orbital Shaker</td>
<td>Thermo Scientific</td>
<td>MaxQ 4000SHKE4000 8CE</td>
</tr>
<tr>
<td>CO<sub>2</sub> incubator cell</td>
<td>Thermo Electron Corporation</td>
<td>HEPA Class 100</td>
</tr>
<tr>
<td>Biological Safety cabinet</td>
<td>Forma Scientific</td>
<td>Class II A/B3 Model 1184</td>
</tr>
</tbody>
</table>
</section>
<section>
<h2 id="materials-and-equipment">Materials and equipment</h2>
<h3 id="sec2.1">Solution preparation</h3>
<div class="note">
<span class="note-title">Note:</span> All procedures are performed with standard aseptic practices, such as a sterile laminar flow cell culture hood in all steps. Additionally, all solutions should be prepared using double-distilled purified water.</div>
<table id="undtbl1">
<caption>ADS buffer 10×, 100 mL</caption>
<thead>
<tr>
<th>Reagent</th>
<th>Final concentration (mM)</th>
<th>Molecular weight</th>
<th>Amount (g)</th>
</tr>
</thead>
<tbody>
<tr>
<td>NaCl</td>
<td>11.64</td>
<td>58.44</td>
<td>6.8</td>
</tr>
<tr>
<td>KCl</td>
<td>0.54</td>
<td>74.55</td>
<td>0.4</td>
</tr>
<tr>
<td>HEPES sodium salt</td>
<td>1.83</td>
<td>260.29</td>
<td>4.76</td>
</tr>
<tr>
<td>NaH2PO4</td>
<td>0.08</td>
<td>141.96</td>
<td>0.12</td>
</tr>
<tr>
<td>Glucose</td>
<td>0.56</td>
<td>180.16</td>
<td>1.0</td>
</tr>
<tr>
<td>MgSO4 x 7H2O</td>
<td>0.04</td>
<td>246.48</td>
<td>0.1</td>
</tr>
<tr>
<td>ddH2O</td>
<td>n/a</td>
<td>n/a</td>
<td>100 mL</td>
</tr>
<tr>
<td>Total</td>
<td>n/a</td>
<td>n/a</td>
<td>100 mL</td>
</tr>
</tbody>
</table>
<p class="table-legend">Note: pH 7.35 ± 0.05<br> The solution needs to be sterilized through 0.22 μm filter.</p>
<table id="undtbl2">
<caption>ADS buffer 1×, 500 mL</caption>
<thead>
<tr>
<th>Reagent</th>
<th>Final concentration</th>
<th>Amount</th>
</tr>
</thead>
<tbody>
<tr>
<td>ADS buffer 10×</td>
<td>1×</td>
<td>50 mL</td>
</tr>
<tr>
<td>ddH<sub>2</sub>O</td>
<td>n/a</td>
<td>450 mL</td>
</tr>
<tr>
<td><b>Total</b></td>
<td><b>n/a</b></td>
<td><b>500 mL</b></td>
</tr>
</tbody>
</table>
<p class="table-legend">Note: pH 7.35 ± 0.05<br> The solution needs to be sterilized through 0.22 μm filter.</p>
<table id="undtbl3">
<caption>Collagenase buffer, 60 mL</caption>
<thead>
<tr>
<th>Reagent</th>
<th>Final concentration</th>
<th>Amount</th>
</tr>
</thead>
<tbody>
<tr>
<td>ADS buffer 1×</td>
<td>1×</td>
<td>60 mL</td>
</tr>
<tr>
<td>Pancreatin</td>
<td>0.2 mg/mL</td>
<td>12 mg</td>
</tr>
<tr>
<td>Collagenase II</td>
<td>207 U/mL</td>
<td>12,420 U</td>
</tr>
<tr>
<td><b>Total</b></td>
<td>n/a</td>
<td>60 mL</td>
</tr>
</tbody>
</table>
<p class="table-legend">Note: The solution needs to be sterilized through the filter 0.22μm and should be used immediately; do not store it.</p>
<table id="undtbl4">
<caption>Percoll stock solution, 20 mL</caption>
<thead>
<tr>
<th>Reagent</th>
<th>Final concentration</th>
<th>Amount</th>
</tr>
</thead>
<tbody>
<tr>
<td>Percoll</td>
<td>90%</td>
<td>18 mL</td>
</tr>
<tr>
<td>ADS 10×</td>
<td>n/a</td>
<td>2 mL</td>
</tr>
<tr>
<td><b>Total</b></td>
<td>n/a</td>
<td>20 mL</td>
</tr>
</tbody>
</table>
<p class="table-legend">Note: Should be used immediately, do not store.</p>
<table id="undtbl5">
<caption>Low-density Percoll separation solution (density = 1.059), 20 mL</caption>
<thead>
<tr>
<th>Reagent</th>
<th>Final concentration</th>
<th>Amount</th>
</tr>
</thead>
<tbody>
<tr>
<td>Percoll stock solution</td>
<td>40.5%</td>
<td>9 mL</td>
</tr>
<tr>
<td>ADS 1×</td>
<td>n/a</td>
<td>11 mL</td>
</tr>
<tr>
<td><b>Total</b></td>
<td>n/a</td>
<td>20 mL</td>
</tr>
</tbody>
</table>
<p class="table-legend">Note: Should be used immediately, do not store.</p>
<table id="undtbl6">
<caption>High-density Percoll separation solution (density = 1.082), 16.8 mL</caption>
<thead>
<tr>
<th>Reagent</th>
<th>Final concentration</th>
<th>Amount</th>
</tr>
</thead>
<tbody>
<tr>
<td>Percoll stock solution</td>
<td>58.9%</td>
<td>11 mL</td>
</tr>
<tr>
<td>ADS 1×</td>
<td>n/a</td>
<td>5.8 mL</td>
</tr>
<tr>
<td>Phenol red</td>
<td>0.02mM</td>
<td>7 mg</td>
</tr>
<tr>
<td><b>Total</b></td>
<td>n/a</td>
<td>∼16.8 mL</td>
</tr>
</tbody>
</table>
<p class="table-legend">Note: Should be used immediately, do not store.</p>
<table id="undtbl7">
<caption>Plating culture medium (pH 7.4), 200 mL</caption>
<thead>
<tr>
<th>Reagent</th>
<th>Final concentration</th>
<th>Amount</th>
</tr>
</thead>
<tbody>
<tr>
<td>Horse serum</td>
<td>10%</td>
<td>20 mL</td>
</tr>
<tr>
<td>Fetal bovine serum</td>
<td>5%</td>
<td>10 mL</td>
</tr>
<tr>
<td>Pen/Strep</td>
<td>1%</td>
<td>2 mL</td>
</tr>
<tr>
<td>DMEM</td>
<td>n/a</td>
<td>200 mL</td>
</tr>
<tr>
<td><b>Total</b></td>
<td>n/a</td>
<td>200 mL</td>
</tr>
</tbody>
</table>
<table id="undtbl8">
<caption>Maintaining culture medium (pH 7.4), 200 mL</caption>
<thead>
<tr>
<th>Reagent</th>
<th>Final concentration</th>
<th>Amount</th>
</tr>
</thead>
<tbody>
<tr>
<td>Fetal bovine serum</td>
<td>2%</td>
<td>4 mL</td>
</tr>
<tr>
<td>Pen/Strep</td>
<td>1%</td>
<td>2 mL</td>
</tr>
<tr>
<td>DMEM</td>
<td>n/a</td>
<td>200 mL</td>
</tr>
<tr>
<td><b>Total</b></td>
<td>n/a</td>
<td>200 mL</td>
</tr>
</tbody>
</table>
<p class="table-legend">Note: Warm the medium to 37°C before use.</p>
<table id="undtbl9">
<caption>PBS buffer 1×, 1 L</caption>
<thead>
<tr>
<th>Reagent</th>
<th>Final concentration (mM)</th>
<th>Molecular weight (g/mol)</th>
<th>Amount (g)</th>
</tr>
</thead>
<tbody>
<tr>
<td>NaCl</td>
<td>137</td>
<td>58.44</td>
<td>8.01</td>
</tr>
<tr>
<td>KCl</td>
<td>2.7</td>
<td>74.55</td>
<td>0.20</td>
</tr>
<tr>
<td>Na<sub>2</sub>HPO<sub>4</sub>
</td>
<td>10</td>
<td>141.96</td>
<td>1.42</td>
</tr>
<tr>
<td>KH<sub>2</sub>PO<sub>4</sub>
</td>
<td>1.8</td>
<td>136.08</td>
<td>0.24</td>
</tr>
<tr>
<td>ddH2O</td>
<td>n/a</td>
<td>n/a</td>
<td>Up to 1L</td>
</tr>
<tr>
<td><b>Total</b></td>
<td>n/a</td>
<td>n/a</td>
<td>1L</td>
</tr>
</tbody>
</table>
<p class="table-legend">Note: pH 7.4 ± 0.05</p>
</section>
<section>
<h2 id="step-by-step-method-details">Step-by-step method details</h2>
<h3 id="sec3.1">Harvesting heart ventricles from neonatal rat</h3>
<div class="timing">
<span class="timing-title">Timing:</span> 1 h</div>
<div class="critical">
<span class="critical-title">Critical:</span> Sterilize scissors (one curved; one straight) and forceps.</div>
<div class="note">
<span class="note-title">Note:</span> All following steps are performed in the sterile cell-culture hood.</div>
<ol>
<li>Transfer 20 mL of 1× ADS buffer into each of the two sterile 100 mm dishes placed on ice.</li>
<li>Prepare 60 mL of Collagenase Buffer in 100 mL sterile Beaker.</li>
<li>Filter 15 mL of Collagenase Buffer with a 0.22 μm filter using a syringe in a 100 mL sterile laboratory bottle (Schott) with cap.</li>
</ol>
<div class="note">
<span class="note-title">Note:</span> The Collagenase Buffer volume for the first digestion is 15 mL. For the following digestions, the volume is reduced to 10 mL.</div>
<ol start="4">
<li>1–3 days old neonatal rats are rinsed quickly in 75% ethanol solution for surface sterilization. The ethanol was spread using a wash bottle before decapitation focusing on the pup’s chest. Pups are decapitated using sterile scissors (straight), and the chest is opened along the sternum to allow access to the chest cavity and the heart.</li>
<li>Hearts are extracted from the body with curved scissors and transferred immediately into the 100 mm dish containing ∼20 mL of 1× ADS buffer.</li>
<li>Remove lung tissue, large vessels and atria. Rinse the heart in the 1× ADS solution to remove blood.</li>
<li>Transfer the heart to the second 100 mm dish containing 1× ADS to remove any additional blood.</li>
<li>Using a scissor, cut the hearts in 4–5 pieces directly into the 100 mL Schott containing 10 mL of filtered Collagenase Buffer (<a href="#fig1">Figures 1</a>A and 1B).
<figure id="fig1"><img src="https://prod-shared-star-protocols.s3.amazonaws.com/protocols/1171-Fig1.jpg" alt="Fig1.jpg">
<figcaption>
<div class="figcaption-title">Figure 1. Enzymatic digestion of cardiac tissue and Percoll gradient separation</div>
<p>(A and B) The heart ventricles were minced in 4–6 pieces and transfer to a bottle containing 10 mL of Collagenase Buffer.</p>
<p>(C) For optimal digestion, the enzymatic solution with the cardiac tissue was placed under agitation at 37°C, 180 rpm.</p>
<p>(D) After ∼60 min, the cardiac tissue is almost complete digested.</p>
<p>(E–G) Cardiomyocyte enrichment step by discontinuous Percoll gradient centrifugation.</p>
<p>(H) After 16 h in culture, check the cells under microscopy for shape, adhesion and spontaneous contractions (see <a href="#mmc2">Methods video S2</a>) (40× magnification).</p>
</figcaption>
</figure>
</li>
<li>Repeat the procedure (steps 4–8) with the remaining pups</li>
<li>After the last heart has been collected and cut into small pieces, cap the Schott and incubate the heart tissue with the collagenase solution under continuous agitation,180 rpm, at 37°C for 10 min (<a href="#fig1">Figure 1</a>C).</li>
</ol>
<h3 id="sec3.2">Enzymatic tissue digestion</h3>
<div class="timing">
<span class="timing-title">Timing:</span> 2 h</div>
<div class="critical">
<span class="critical-title">Critical:</span> The digestion temperature (37°C) is a crucial point for the complete digestion of the hearts.</div>
<ol start="11">
<li>After 10 min, use a sterile 10 mL serological pipette to pipette up and down 10 times to homogenize the sample and improve the tissue dissociation.</li>
<li>Allow the tissues to settle by gravity for 1 min, collect the supernatant (approximately 11 mL) and transfer to 50 mL conical tubes.</li>
<li>Add 10 mL 0.22 μm filtered Collagenase Buffer solution to the remaining cardiac tissue and incubate under 180 rpm agitation at 37°C for 10 min.</li>
</ol>
<div class="note">
<span class="note-title">Note:</span> The shaker utilized here display an orbital motion rage of 1.9 cm (0.75 in).</div>
<ol start="14">
<li>Stop enzymatic degradation by removing the Schott from the 37°C shaker and by adding 1 mL of fetal bovine serum to the 50 mL conical tube containing the 11 mL of the supernatant (step 12).</li>
<li>Centrifuge at 2,000×<i>g</i> for 5 min at 25°C.</li>
<li>Carefully discard the supernatant and add 2 mL of the fetal bovine serum to the cell pellet and homogenize pipetting up and down using a serological pipette.</li>
<li>Transfer the cell suspension to a sterilized 100 mm glass petri dish (non-treated) to allow the fibroblasts to adhere. Incubate at 37°C, 5% CO<sub>2</sub> for at least 1 h, the time it takes to finish all digestions.</li>
<li>Repeat the digestion, centrifugation and the pre-plating process (steps 11–17) 4–5 times with the remaining tissue fragments.</li>
<li>After finishing the last digestion (<a href="#fig1">Figure 1</a>D) and pre-plating cycle, transfer the supernatant of all five Petri dishes into a 50 mL conical tube.</li>
</ol>
<div class="note">
<span class="note-title">Note:</span> Pre plating is a process that consists in seeding the cells on an uncoated glass petri dish to allow fibroblasts and endothelial cells to adhere, improving the purity of the culture. In addition to increasing the purity of the cardiomyocyte isolation, this procedure enables isolated and cultivate high yields of cardiac fibroblasts and endothelial cells from neonatal rats.</div>
<div class="note">
<span class="note-title">Note:</span> The number of Petri dishes used in this step is variable accordantly to the number of digestion cycles performed in step 18.</div>
<ol start="20">
<li>Gently wash the Petri dishes with 6 mL fetal bovine serum and transfer the supernatant to one conical tube.</li>
<li>Centrifuge at 2,000×<i>g</i> for 10 min at 25°C.</li>
<li>Resuspend the cells in 3 mL of 1× ADS buffer.</li>
</ol>
<div class="note">
<span class="note-title">Note:</span> The Petri dishes have a high yield of viable primary fibroblasts attached and can be maintained in Culture Medium for further experiments. Cardiac fibroblasts in culture proliferate to form a confluent monolayer. Please refer to <a href="#bib4">Golden et al. (2012)</a>.</div>
<h3 id="sec3.3">Percoll gradient separation</h3>
<div class="timing">
<span class="timing-title">Timing:</span> 1 h 40 min</div>
<ol start="23">
<li>In this step, a high yield of viable cardiomyocytes will be separated from non-cardiomyocytes using two-step discontinuous Percoll gradient centrifugation.</li>
<li>Prepare the two-layers Percoll gradient in a 15 mL conical centrifuge tube. For 30–40 hearts, prepare four 15 mL centrifuge tubes.</li>
<li>To each of the four 15 mL centrifuge tubes, the two-layers Percoll density gradient is created by carefully loading 4 mL of the low-density Percoll solution on top of the 4 mL of the high-density Percoll solution (<a href="#fig1">Figure 1</a>E). Tilt the tube during this procedure to avoid mixing the Percoll layers.</li>
<li>Slowly load up to 1 mL of cell suspension (obtained in step 22) on the top layer of the Percoll gradient prepared above. During cell loading, the tube should be tilted (<a href="#fig1">Figure 1</a>F and <a href="#mmc1">Methods video S1</a>).</li>
<li>Centrifuge the tubes at 1,800×<i>g</i> for 45 min at 25°C.</li>
</ol>
<div class="critical">
<span class="critical-title">Critical:</span> This step requires that acceleration and deceleration be switched off completely to prevent the layers' remix. Therefore, the centrifuge accelerates and stop slowly, avoiding disturbing the Percoll gradient.</div>
<ol start="28">
<li>After centrifugation, the NRVMs are located at the interface of the low and high-density gradients (<a href="#fig1">Figure 1</a>G).</li>
<li>Using a sterile 5 mL pipette, start carefully discarding the layers corresponding to the high-density Percoll layer or non-cardiomyocytes.</li>
<li>Repeat this step with the remaining centrifuged tubes.</li>
<li>Using a new sterile 5 mL pipette, collect the band corresponding to the NRVMs and transfer it to a further 50 mL conical centrifuge tube.</li>
<li>Repeat this procedure with the remaining centrifuged tubes and combine them into the same 50 mL conical tube.</li>
<li>Add 30 mL of 1× ADS buffer.</li>
<li>Centrifuge the 50 mL tube at 1,800×g for 10 min at 25°C. Discard the supernatant in a waste container.</li>
<li>Gently resuspend the cell pellet by pipetting 30 mL of 1× ADS buffer and repeat the previous wash step (step 34).</li>
<li>Resuspend the pellet with 5 mL of warm Plating Culture Medium by gently pipetting to ensure a homogeneous solution of single cells.</li>
</ol>
<figure id="mmc1"><video controls="controls">
    <source src="https://prod-shared-star-protocols.s3.amazonaws.com/protocols/1171-Mmc1.mp4" type="video/mp4">
    Your browser does not support HTML5 video.
  </source></video>
<figcaption>
<div class="figcaption-title">Methods video S1. Loading the cell suspension on the top layer of the Percoll gradient, related to step 26</div>
<p>Check that the tube should be titled during cell loading.</p>
</figcaption>
</figure>
<h3 id="sec3.4">Counting and plating the cells</h3>
<div class="timing">
<span class="timing-title">Timing:</span> 40 min</div>
<p>The NRVMs yield and viability are determined by a Neubauer chamber and trypan blue staining. Trypan blue staining is used to indicate the ratio of live to dead cells as the stain turns dead cells that have compromised membranes blue, while live cells will remain colorless.</p>
<ol start="37">
<li>Take 10 μL of resuspended cells (step 36) into a new 1.5 mL tube and add 10 μL of 0.4% trypan blue dye solution. Mix gently.</li>
<li>Load 10 μL of the mixture above into the well of the Neubauer counting chamber.</li>
<li>Using the microscope to focus on the grid of the Neubauer counting chamber determine the total number of viable cells, following the standard procedure for counting cells and the calculation for determining total cell number.</li>
<li>Add 3 mL of fresh Plating Culture Medium per 35 mm dish or per well in 6-wells plate.</li>
<li>Plate the cells on the double coated surface. For immunostaining, we recommend 500,000 cells/ 35 mm dish or per well in a 6-wells plate containing coverslip on the bottom to achieve 70–80% of confluence.</li>
</ol>
<div class="note">
<span class="note-title">Note:</span> If desired, before plating, add Bromodeoxyuridine (BrdU), a thymidine analog (100 μM final concentration), to avoid the proliferation of non-myocytes.</div>
<ol start="42">
<li>Incubate at 37°C, 5% CO<sub>2</sub>.</li>
<li>Forty-eight hours after plating, gently change the medium with 3 mL of Maintaining culture medium. Using the microscope confirm that NRVMs are attached and exhibit spontaneous beating (<a href="#mmc2">Methods video S2</a>). Any non-attached cells should be removed during the medium exchange procedure. At this point, any treatment, transfection or virus transduction may be performed according to the experimental design.</li>
</ol>
<figure id="mmc2"><video controls="controls">
    <source src="https://prod-shared-star-protocols.s3.amazonaws.com/protocols/1171-Mmc2.mp4" type="video/mp4">
    Your browser does not support HTML5 video.
  </source></video>
<figcaption>
<div class="figcaption-title">Methods video S2. NRVMs displays spontaneous contractility in vitro, related to step 43</div>
</figcaption>
</figure>
<h3 id="sec3.5">Immunofluorescence staining</h3>
<div class="timing">
<span class="timing-title">Timing:</span> 2 days</div>
<ol start="44">
<li>Remove the medium and rinse briefly in 1× phosphate-buffered saline (PBS).</li>
<li>Fix cells with 4% paraformaldehyde in PBS pH 7.4 for 30 min on ice (<a href="#fig2">Figure 2</a>A).
<figure id="fig2"><img src="https://prod-shared-star-protocols.s3.amazonaws.com/protocols/1171-Fig2.jpg" alt="Fig2.jpg">
<figcaption>
<div class="figcaption-title">Figure 2. Immunofluorescence staining and imaging</div>
<p>(A) Fix the cells with 4% paraformaldehyde in PBS.</p>
<p>(B) Blocking any unspecific antibodies binding by incubating the cell with 1% BSA, 50 mM glycine in PBS.</p>
<p>(C) Incubate with primary antibody.</p>
<p>(D) Incubate the cells with a secondary antibody.</p>
<p>(E) Alternatively, incubate the cells with phalloidin-rodhamin and DAPI.</p>
<p>(F) Mounting the coverslip using mounting medium Vectashield.</p>
<p>(G) Representative images of cardiomyocytes staining with phalloidin in green and Dapi in blue.</p>
<p>(H) Representative pictures of cardiomyocytes staining with α-actinin antibody in red and Dapi in blue.</p>
<p>(I) Representative images of cardiomyocytes stained with MEF2 antibody in green, phalloidin in red and Dapi in blue. Scale bar, 10 μm.</p>
</figcaption>
</figure>
</li>
<li>Wash three times for 5 min with 1× ice-cold PBS.</li>
<li>Next, permeabilize and block any unspecific binding of the antibodies by incubating the cell with 1% BSA, 0.1% Triton-X100, 50 mM glycine in PBS for 30 min (<a href="#fig2">Figure 2</a>B).</li>
<li>Wash three times for 5 min with 1× PBS.</li>
<li>Incubate the cells with primary antibodies (1:200 dilution) in 1% BSA in PBS overnight at 4°C (<a href="#fig2">Figure 2</a>C).</li>
<li>Wash three times for 5 min with 1× PBS.</li>
<li>Incubate the cells with Alexa Fluor-conjugated secondary antibody (1:200) for 2 h at room temperature. All subsequent steps should be carried out in the dark as fluorescent probes are light sensitive (<a href="#fig2">Figure 2</a>D).</li>
<li>Wash three times for 5 min with 1× PBS.</li>
<li>If applied, perform the cytosolic staining with phalloidin (1:50) for 1 h at room temperature (<a href="#fig2">Figure 2</a>E).</li>
</ol>
<div class="note">
<span class="note-title">Note:</span> Please use fluorophores with different emission spectra in multi-color immunofluorescence experiments to avoid spectral overlap.</div>
<ol start="54">
<li>Wash for 5 min with 1× PBS.</li>
<li>Incubate with the nuclear stain DAPI (1:500) at room temperature for 5 min (<a href="#fig2">Figure 2</a>E).</li>
<li>Wash for 5 min with 1× PBS.</li>
<li>Place the coverslip onto a drop of mounting media (Vectashield) with the cells facing the slide (<a href="#fig2">Figure 2</a>F).</li>
<li>Seal the coverslip with nail polish by gently outlining the perimeter of the slide.</li>
<li>Samples can then be examined using a fluorescence microscope (<a href="#fig2">Figures 2</a>G–2I) or stored in the dark at −20°C.</li>
</ol>
</section>
<section>
<h2 id="expected-outcomes">Expected outcomes</h2>
<p>A high yield of viable cardiomyocytes was isolated from 25 neonatal rat hearts through our protocol. The average result of purified cells was (1.27 ± 0.11) x 10<sup>6</sup> cells per neonatal heart, and the average viability accessed by Trypan blue staining was approximately 80 ± 3.3% (n=3). The cardiomyocyte purity calculated by the ratio of myocyte specific antibody (sarcomeric α-actinin) positive cells to total cells determined by DAPI nuclear staining was 87 ± 2.08% (n=3). Our results are similar to previous studies that reported approximately 1 × 10<sup>6</sup> NRVM per neonate rat heart with 70–90% viability (GOLDEN, H. B et al., 2012). The cardiomyocytes can be maintained in culture for 6–7 days with a medium change every two days. Sixteen hours after plating, the cardiomyocytes can be observed under the microscopy for attachment to the laminin-coated cell culture dishes (with approximately 70–80% confluency) (<a href="#fig1">Figure 1</a>H) and display spontaneous contractility (<a href="#mmc2">Methods video S2</a>).</p>
</section>
<section>
<h2 id="limitations">Limitations</h2>
<h3 id="sec5.1">Addition of proliferation inhibitors</h3>
<p>Even with the pre-plating step followed by the Percoll gradient separation to improve cardiomyocyte purity, the remaining population of nonmyocytes, such as cardiac fibroblasts and endothelial cells, will undergo cell proliferation at high rate, and significantly affect the cell-population over time. Therefore, the addition of proliferation inhibitors, such as Bromodeoxyuridine (BrdU) to the Maintaining Culture Medium is recommended to prevent the proliferation of nonmyocytes. However, the addition of proliferation inhibitors may affect the experimental design and results interpretation(<a href="#bib3">Ehler et al., 2013</a>). Therefore, proliferation inhibitors must be used with caution depending on experimental purposes.</p>
<h3 id="sec5.2">Non-viral transfection of NRVMs</h3>
<p>The efficiency of transfection of NRVMs with liposomal reagents or electroporation is limited, typically reported lower than 10% (<a href="#bib3">Ehler et al., 2013</a>). Alternatively, gene transfer using viral vectors (such as adenovirus, adeno-associated virus, and retrovirus) have been reported to achieve higher efficiency rates (<a href="#bib2">Djurovic et al., 2004</a>), with minimal impact in cell viability and cellular morphology (<a href="#bib1">Consonni et al., 2021</a>). For more details about gene transfer in culture cardiomyocytes, please refer to (<a href="#bib2">Djurovic et al., 2004</a>).</p>
<h3 id="sec5.3">Passaging and cryopreservation</h3>
<p>Subculturing the primary cardiomyocytes is challenging and not recommendable (<a href="#bib3">Ehler et al., 2013</a>). The cardiomyocyte viability and beating capacity were significantly reduced during this procedure.</p>
</section>
<section>
<h2 id="troubleshooting">Troubleshooting</h2>
<h3 id="sec6.1">Problem 1</h3>
<p>Cardiac tissue does not digest appropriately; the amount of the tissue does not decrease after 5–6 rounds of digestion. (Step 17)</p>
<h3 id="sec6.2">Potential solution</h3>
<p>Check the temperature of the shaker.</p>
<p>Increase the enzyme concentration.</p>
<p>Add 0.2mg/mL of DNaseI to Collagenase Buffer</p>
<h3 id="sec6.3">Problem 2</h3>
<p>Low cell viability (many trypan blue positive cells). (Step 39)</p>
<h3 id="sec6.4">Potential solution</h3>
<p>Reduce the digestion time. It is not recommended more than 5–6 rounds of digestion due to loss of cell viability</p>
<p>Reduce the pre-plating time. Pre-plating time longer than 2–3 h may reduce the cell viability</p>
<p>Check the centrifuge speed and temperature</p>
<p>Check the pH of the solutions</p>
<h3 id="sec6.5">Problem 3</h3>
<p>No viable or adherent NRVMs 16–18 h after plating. (Step 43)</p>
<h3 id="sec6.6">Potential solution</h3>
<p>Try different substrate coatings like collagen or gelatin.</p>
<p>Check cell culture incubator (temperature, humidity and CO<sub>2</sub>)</p>
<p>Check for contamination</p>
<h3 id="sec6.7">Problem 4</h3>
<p>The percoll layers are not observed, or no layer forms on the Percoll gradient. (Step 28)</p>
<h3 id="sec6.8">Potential solution</h3>
<p>Check the brake and acceleration of centrifugation.</p>
<p>The ADS 1× solution should be done from the same ADS 10× stock solution.</p>
<h3 id="sec6.9">Problem 5</h3>
<p>Immunofluorescence staining does not work, or unspecific staining. (Step 59)</p>
<h3 id="sec6.10">Potential solution</h3>
<p>Increase antibody concentration.</p>
<p>Increase blocking time.</p>
<p>The secondary antibody control should be performed following the same staining protocol without the addition of the primary antibody</p>
</section>
<section>
<h2 id="references">References</h2>
<p id="bib1">Consonni, S.R., de Carvalho, A., Mauro, A.B., Franchini, K.G., and Bajgelman, M.C. (2021). Lentiviral transduction of neonatal rat ventricular myocytes preserves ultrastructural features of genetically modified cells. Virology <i>562</i>, 190-196. <a class="external-link" href="http://refhub.elsevier.com/S2666-1667(21)00656-0/sref1">View at publisher</a></p>
<p id="bib2">Djurovic, S., Iversen, N., Jeansson, S., Hoover, F., and Christensen, G. (2004). Comparison of nonviral transfection and adeno-associated viral transduction on cardiomyocytes. Mol. Biotechnol. <i>28</i>, 21-32. <a class="external-link" href="http://refhub.elsevier.com/S2666-1667(21)00656-0/sref2">View at publisher</a></p>
<p id="bib3">Ehler, E., Moore-Morris, T., and Lange, S. (2013). Isolation and culture of neonatal mouse cardiomyocytes. J. Vis. Exp. <i>79</i>, e50154. <a class="external-link" href="http://refhub.elsevier.com/S2666-1667(21)00656-0/sref3">View at publisher</a></p>
<p id="bib4">Golden, H.B., Gollapudi, D., Gerilechaogetu, F., Li, J., Cristales, R.J., Peng, X., and Dostal, D.E. (2012). Isolation of cardiac myocytes and fibroblasts from neonatal rat pups. Methods Mol. Biol. <i>843</i>, 205-214. <a class="external-link" href="http://refhub.elsevier.com/S2666-1667(21)00656-0/sref4">View at publisher</a></p>
<p id="bib5">Pereira, A.H.M., Cardoso, A.C., Consonni, S.R., Oliveira, R.R., Saito, A., Vaggione, M.L.B., Matos-Souza, J.R., Carazzolle, M.F., Goncalves, A., Fernandes, J.L., et al. (2020). MEF2C repressor variant deregulation leads to cell cycle re-entry and development of heart failure. EBioMedicine <i>51</i>, 102571. <a class="external-link" href="http://refhub.elsevier.com/S2666-1667(21)00656-0/sref5">View at publisher</a></p>
</section>
<section>
<h2 id="article-info">Article info</h2>
<h3>Resource availability</h3>
<h4>Lead contact</h4>
<p>Further information and requests for resources and reagents should be directed to the lead contact Kleber Gomes Franchini (<a href="mailto:kleber.franchini@lnbio.cnpem.br">kleber.franchini@lnbio.cnpem.br</a>)</p>
<h4>Materials availability</h4>
<p>This study did not generate new unique reagents.</p>
<h4>Data and code availability</h4>
<p>This study did not generate any unique datasets or code.</p>
<h3>Acknowledgments</h3>
<p>This work was supported partly by the <a href="https://doi.org/10.13039/501100011874">CNPEM</a> (Brazilian Center for Research in Energy and Materials) and Brazilian National Research Council (<a href="https://doi.org/10.13039/501100003593">CNPq</a>; Grant 307498/2019-0). The funding agency had no involvement in the design, performance, or analysis of the study.</p>
<h3>Author contributions</h3>
<p>A.H.M.P. conducted most of the experiments and data analysis. A.C.C. performed partial experiments and data analysis. A.H.M.P. and A.C.C. wrote the manuscript. K.G.F. supervised the project and revised the manuscript.</p>
<h3>Declaration of interests</h3>
<p>The authors declare no competing interests.</p>
</section>
</article>